0001209191-20-025177.txt : 20200420
0001209191-20-025177.hdr.sgml : 20200420
20200420202017
ACCESSION NUMBER: 0001209191-20-025177
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200417
FILED AS OF DATE: 20200420
DATE AS OF CHANGE: 20200420
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Pang Phillip
CENTRAL INDEX KEY: 0001787370
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39083
FILM NUMBER: 20803728
MAIL ADDRESS:
STREET 1: C/O VIR BIOTECHNOLOGY, INC.
STREET 2: 499 ILLINOIS STREET, SUITE 500
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94158
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Vir Biotechnology, Inc.
CENTRAL INDEX KEY: 0001706431
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 812730369
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 499 ILLINOIS STREET
STREET 2: SUITE 500
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94158
BUSINESS PHONE: 415-906-4324
MAIL ADDRESS:
STREET 1: 499 ILLINOIS STREET
STREET 2: SUITE 500
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94158
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-04-17
0
0001706431
Vir Biotechnology, Inc.
VIR
0001787370
Pang Phillip
C/O VIR BIOTECHNOLOGY, INC.
499 ILLINOIS STREET, SUITE 500
SAN FRANCISCO
CA
94158
0
1
0
0
Chief Medical Officer
Common Stock
2020-04-17
4
M
0
8000
0.855
A
15777
D
Employee Stock Option (Right to Buy)
0.855
2020-04-17
4
M
0
8000
0.00
D
2027-03-09
Common Stock
8000
95333
D
1/4 of the 111,111 shares originally subject to the stock option vested and became exercisable on December 14, 2017, and the remaining shares vest in 36 equal monthly installments thereafter. The aggregate number of shares subject to the stock option has been reduced by one share to 111,110 shares due to rounding in connection with a partial exercise of the stock option and a reverse stock split effected prior to the Issuer's initial public offering.
/s/ Howard Horn, Attorney-in-Fact
2020-04-20